ROCK2 and asthma: Furthermore, the absence of changes in MYPT1 phosphorylation at Thr696 and Thr850 suggests that ROCK2-mediated inhibition may occur through alternative or non-canonical pathways, such as phosphorylation at Ser507 previously reported in asthma models, guiding future studies toward alternative phosphorylation sites [14].